Regeneron Pharmaceuticals (REGN) Announces Collaboration With Telix Pharmaceuticals Limited [Yahoo! Finance]
Regeneron Pharmaceuticals, Inc. (REGN)
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.regeneron.com
Company Research
Source: Yahoo! Finance
on April 13 a collaboration with Telix Pharmaceuticals Limited aimed at the joint development and commercialization of next-generation radiopharmaceutical therapies. Management stated that the collaboration brings together Regeneron Pharmaceuticals' (NASDAQ:REGN) biologics expertise, including bispecific antibody discovery, with Telix's radiopharmaceutical development platform, global manufacturing capabilities, and supply chain infrastructure. It further reported that the collaboration will include several solid tumor targets from Regeneron Pharmaceuticals' (NASDAQ:REGN) portfolio of antibodies, generated from VelocImmune ® mice. The agreement also aims at developing radio-diagnostics to support patient selection and treatment response assessment, in line with the two companies' shared commitment to precision oncology. Regeneron (REGN) Draws Higher Target From TD Cowen The terms of the agreement state that Telix will receive an upfront cash payment of $40 million from Regeneron P
Show less
Read more
Impact Snapshot
Event Time:
REGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
REGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
REGN alerts
High impacting Regeneron Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
REGN
News
- NTLA Stock Rises 20% in 3 Months: Here's What You Should Know [Yahoo! Finance]Yahoo! Finance
- Why Telix Pharmaceuticals (ASX:TLX) Is Up 13.8% After Regeneron Radiopharma Alliance Announcement And What's Next [Yahoo! Finance]Yahoo! Finance
- Regeneron and Telix Announce Strategic Radiopharma CollaborationGlobeNewswire
- Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)GlobeNewswire
- Telix and Regeneron Announce Strategic Radiopharma CollaborationPR Newswire
REGN
Earnings
- 1/30/26 - Beat
REGN
Sec Filings
- 4/8/26 - Form 8-K
- 4/3/26 - Form 4
- 3/27/26 - Form SCHEDULE
- REGN's page on the SEC website